CCM
Compass Capital Management Portfolio holdings
AUM
$1.87B
This Quarter Return
+6.43%
1 Year Return
+12.77%
3 Year Return
+56.2%
5 Year Return
+94.92%
10 Year Return
+239.3%
AUM
$581M
AUM Growth
+$581M
(+8.4%)
Cap. Flow
+$9.22M
Cap. Flow
% of AUM
1.59%
Top 10 Holdings %
Top 10 Hldgs %
41.29%
Holding
44
New
1
Increased
22
Reduced
16
Closed
1
Top Buys
| 1 |
Qualcomm
QCOM
|
$2.85M |
| 2 |
Johnson Controls International
JCI
|
$1.75M |
| 3 |
Walmart
WMT
|
$1.22M |
| 4 |
Accenture
ACN
|
$713K |
| 5 |
CVS Health
CVS
|
$690K |
Top Sells
| 1 |
Check Point Software Technologies
CHKP
|
$899K |
| 2 |
Wells Fargo
WFC
|
$588K |
| 3 |
Fastenal
FAST
|
$390K |
| 4 |
Sherwin-Williams
SHW
|
$314K |
| 5 |
Pfizer
PFE
|
$216K |
Sector Composition
| 1 | Industrials | 23.58% |
| 2 | Healthcare | 23.35% |
| 3 | Technology | 20.03% |
| 4 | Financials | 8.43% |
| 5 | Consumer Staples | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Omnicom Group
OMC
$15.2B
| $1.45M | 0.25% |
16,761
-85
| -0.5% | -$7.33K |
|
27
Target
TGT
$43.6B
| $1.1M | 0.19% |
19,994
-1,463
| -7% | -$80.7K |
|
28
Exxon Mobil
XOM
$487B
| $1.07M | 0.18% |
13,073
-1,295
| -9% | -$106K |
|
29
3M
MMM
$82.8B
| $923K | 0.16% |
4,825
+400
| +9% | +$76.5K |
|
30
Conagra Brands
CAG
$9.16B
| $879K | 0.15% |
21,800
-465
| -2% | -$18.7K |
|
31
McDonald's
MCD
$224B
| $607K | 0.1% |
4,686
| – | – |
|
32
PepsiCo
PEP
$204B
| $606K | 0.1% |
5,419
-200
| -4% | -$22.4K |
|
33
Chevron
CVX
$324B
| $563K | 0.1% |
5,248
| – | – |
|
|
34
Wells Fargo
WFC
$263B
| $493K | 0.08% |
8,858
-10,560
| -54% | -$588K |
|
35
Home Depot
HD
$405B
| $354K | 0.06% |
2,414
-345
| -13% | -$50.6K |
|
36
Walt Disney
DIS
$213B
| $351K | 0.06% |
3,095
-157
| -5% | -$17.8K |
|
37
Lamb Weston
LW
$8.02B
| $343K | 0.06% |
8,153
+732
| +10% | +$30.8K |
|
38
Kimberly-Clark
KMB
$42.8B
| $288K | 0.05% |
2,189
| – | – |
|
39
Apple
AAPL
$3.45T
| $252K | 0.04% |
1,754
-210
| -11% | -$30.2K |
|
40
Schlumberger
SLB
$55B
| $252K | 0.04% |
3,223
+500
| +18% | +$39.1K |
|
|
41
Pfizer
PFE
$141B
| $250K | 0.04% |
7,308
-6,316
| -46% | -$216K |
|
42
Merck
MRK
$210B
| $216K | 0.04% |
+3,396
| New | +$216K |
|
43
Adient
ADNT
$2.01B
| – | – |
-3,677
| Closed | -$215K |
|